Elevated fibrinogen-fibrin degradation products (FDP) in serum of colorectal cancer patients

Analytical Letters

Volumn 37, Issue 14, 2004, Pages 2965-2976

  Rucker, Perry ^a   Antonio, Sheila M ^b   Braden, Barbara ^c  

^a Seashore Tetrachem Inc   (United States)

^b AMDL Inc   (United States)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

CEA; Colorectal cancer; DR 70 ; ELISA; Fibrin fibrinogen degradation products (FDP)

Indexed keywords

FIBRIN; FIBRINOGEN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CANCER PATIENT; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DEVICE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; GERMANY; HUMAN; MALE; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS; UNITED STATES;

EID: 9744250150     PISSN: 00032719     EISSN: None     Source Type: Journal    
DOI: 10.1081/AL-200035849     Document Type: Article

References (16)

1. Rucklidge, G.J.; Edvardsen, K.; Bock, E. Cell-adhesion molecules and metalloproteinases: a linked role in tumour cell invasiveness. Biochemical Society Transaction 1994 (Feb.), 22, 63-68.
2. Ossowski, L.; Quigley, J.P.; Kellerman, G.M.; Reich, E. Fibrinolysis associated with oncogenic transformation. J. Exp. Med. 1973, 138, 1056-1064.
3. Blackwell, K.; Haroon, Z.; Broadwater, G.; Berry, D.; Harris, L.; Iglehart, J.D.; Dewhirst, M.; Greenberg, C. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status. J. Clin. Oncology 2000, 18, 600-608.
4. Dirix, L.Y.; Salgado, R.; Weytjens, R.; Colpaert, C.; Benoy, I.; Huget, P.; van Dam, P.; Prove, A.; Lemmens, J.; Vermeulen, P. Plasma fibrin D-dimer levels correlate with tumor volume, progression rate and survival in patients with metastatic breast cancer. Bri. J. Cancer 2002, 86, 389-395.
5. Palumbo, J.S.; Kombrinck, K.W.; Drew, A.F.; Grimes, T.S.; Kise, J.H.; Degen, J.L.; Bugge, T.H. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 2000, 96, 3302-3309.
6. Okholm, M.; Iversen, L.H.; Thorlacius-Ussing, O.; Ejlersen, E.; Boesby, S. Fibrin and fibrinogen degradation products in plasma of patients with colorectal adenocarcinoma. Dis. Colon Rectum. 1996, 39, 1102-1106.
7. Gerner, C.; Steinkellner, W.; Holzman, K.; Gsur, A.; Grimm, R.; Ensinger, C.; Obrist, P.; Sauermann, G. Elevated plasma level of cross-linked fibrinogen gamma-chain dimmer indicate cancer-related fibrin deposition and fibrinolysis. Thromb. Haemost. 2001, 85, 494-501.
8. Oya, M.; Akiyama, Y.; Yanagida, T.; Akao, S.; Ishikawa, H. Plasma D-Dimer Level in Patients with Colorectal Cancer: Its Role as a Tumor Marker. Surg. Today 1998, 28, 373-378.
9. Wu, D.; Zhou, X.; Yang, G.; Xie, Y.; Hu, M.; Wu, Z.; Yang, G.; Lu, M. Clinical performance of the AMDL DR-70™ immunoassay kit for cancer detection. J. Immunoassay 1998, 19, 63-72.
10. Wu, D.; Zhou, X.; Anderson, G.; Fuentes, A.; Slater, L.M.; Narinesingh, D.; Jimenez, P.; Gopoesingh, T. Sensitivity & specificity of DR-70™ lung cancer immunoassay. Anal. Letters 1999, 32 (7), 1351-1362.
11. Topsakal, M.; Karadeniz, T.; Anac, M.; Donmezer, S.; Besisik, A. Assessment of fibrin-fibrinogen degradation products (AccuDx) test in bladder cancer patients. European Urology 2001, 39, 287-291.
12. Lin, D.; Shen, P.; Yang, J. Application of tumor marker of DR-70® in the diagnosis of malignant tumors (translated from Chinese edition). Chongqing Medical Journal 1999, 28 (5), 1-3.
13. Ngo, T.T.; Cress, M.C.; Moore, R.J. Performance characteristics of a novel immunoassay for cancer detection. IVD Technology 1998, Jan/Feb.
14. Tsihlias, J.; Grossman, H.B. The utility of fibrin/fibrinogen degradation products in superficial bladder cancer. Urologic Clinics of North America 2000, 27 (1), 39-46.
15. McCabe, R.P.; Lamm, D.L.; Haspel, M.V.; Pomato, N.; Smith, K.O.; Thompson, E.; Hana, M.G., Jr. A diagnostic-prognostic test for bladder cancer using a monoclonal antibody-based enzyme-linked immunoassay for detection of urinary fibrin(ogen) degradation products. Cancer Research 1984, 44, 5886-5893.
16. Zweig, M.H.; Robertson, E.A. Clinical validation of immunoassays: A well-design approach to a clinical study. In Immunoassay: A Practical Guide; Chan, D.W., Perlstein, M.T., Eds.; Academic Press: Orlando, 1987; 97-127.